Jump to main content
Jump to site search

Issue 8, 2015
Previous Article Next Article

The role of photodynamic therapy in overcoming cancer drug resistance

Author affiliations

Abstract

Many modalities of cancer therapy induce mechanisms of treatment resistance and escape pathways during chronic treatments, including photodynamic therapy (PDT). It is conceivable that resistance induced by one treatment might be overcome by another treatment. Emerging evidence suggests that the unique mechanisms of tumor cell and microenvironment damage produced by PDT could be utilized to overcome cancer drug resistance, to mitigate the compensatory induction of survival pathways and even to re-sensitize resistant cells to standard therapies. Approaches that capture the unique features of PDT, therefore, offer promising factors for increasing the efficacy of a broad range of therapeutic modalities. Here, we highlight key preclinical findings utilizing PDT to overcome classical drug resistance or escape pathways and thus enhance the efficacy of many pharmaceuticals, possibly explaining the clinical observations of the PDT response to otherwise treatment-resistant diseases. With the development of nanotechnology, it is possible that light activation may be used not only to damage and sensitize tumors but also to enable controlled drug release to inhibit escape pathways that may lead to resistance or cell proliferation.

Graphical abstract: The role of photodynamic therapy in overcoming cancer drug resistance

Back to tab navigation

Publication details

The article was received on 06 Jan 2015, accepted on 10 Mar 2015 and first published on 10 Mar 2015


Article type: Perspective
DOI: 10.1039/C4PP00495G
Citation: Photochem. Photobiol. Sci., 2015,14, 1476-1491
  •   Request permissions

    The role of photodynamic therapy in overcoming cancer drug resistance

    B. Q. Spring, I. Rizvi, N. Xu and T. Hasan, Photochem. Photobiol. Sci., 2015, 14, 1476
    DOI: 10.1039/C4PP00495G

Search articles by author

Spotlight

Advertisements